<DOC>
	<DOCNO>NCT02249169</DOCNO>
	<brief_summary>This longitudinal study do understand mechanism underlie development irritable bowel syndrome ( IBS ) role gut bacteria development symptom . This information use determine whether temporal change gut microbial taxonomy metabolism associate change symptom severity IBS , target dietary intervention , include prebiotics , reverse moderate change .</brief_summary>
	<brief_title>Developing Novel Microbiota-Targeted Therapies Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>IBSC IBSD SUBJECTS : Clinical diagnosis IBSC IBSD Age 18 65 Prior history abdominal surgery ( except appendectomy cholecystectomy ) Known diagnosis inflammatory bowel disease , microscopic colitis , celiac disease inflammatory condition Antibiotic use within past 4 week ( enrol fourweek washout period subsequent use 6month study duration exclude ) Bleeding risk medication may increase risk bleed patient agree undergo flexible sigmoidoscopy Bowel preparation colonoscopy within past week Pregnancy plan become pregnant within study time frame Vulnerable adult Age great equal 66 Any disease ( ) , condition ( ) habit ( ) would interfere completion study , would increase risk flexible sigmoidoscopy ( opt ) , judgment investigator would potentially interfere compliance study would adversely affect study outcomes HEALTHY SUBJECTS : Age 18 65 No clinical diagnosis IBSC IBSD Prior history abdominal surgery ( except appendectomy cholecystectomy ) Known diagnosis inflammatory bowel disease , microscopic colitis , celiac disease inflammatory condition Antibiotic use within past 4 week ( enrol fourweek washout period subsequent use 6month study duration exclude ) Bleeding risk medication may increase risk bleed patient agree undergo flexible sigmoidoscopy Bowel preparation colonoscopy within past week Pregnancy plan become pregnant within study time frame Vulnerable adult Age great equal 66 Any disease ( ) , condition ( ) habit ( ) would interfere completion study , would increase risk flexible sigmoidoscopy ( opt ) , judgment investigator would potentially interfere compliance study would adversely affect study outcomes Clinical diagnosis IBSC IBSD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>IBS</keyword>
</DOC>